YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Drug-Targeted Alerts for Acute Kidney Injury

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Other: Drug-specific alert

First Posted Date: 2016-05-13

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 5060

Registration Number: NCT02771977

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

NICE: NeuroImaging in Cessation Education

Not Applicable

Terminated

Conditions: Smoking Cessation
Stroke

Interventions: Behavioral: standardized smoking cessation counseling
Behavioral: Neuroimages of stroke

First Posted Date: 2016-05-12

Last Posted Date: 2020-08-12

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT02769871

Bright 1 Bodies Weight Management Program

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Behavioral: Bright 1 Bodies

First Posted Date: 2016-05-11

Last Posted Date: 2018-05-30

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT02768987

Locations: 🇺🇸
Yale Children's Diabetes Program, New Haven, Connecticut, United States

Neuroscience of Marijuana Impaired Driving

Phase 1

Completed

Conditions: Marijuana Impairment

Interventions: Drug: Low dose THC marijuana
Drug: High dose THC marijuana
Drug: Placebo marijuana

First Posted Date: 2016-05-02

Last Posted Date: 2024-07-23

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT02757313

Locations: 🇺🇸
Olin Neuropsychiatry Research Center, Hartford, Connecticut, United States

Optimizing Electronic Alerts for Acute Kidney Injury

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Other: AKI Alert

First Posted Date: 2016-04-28

Last Posted Date: 2022-02-10

Lead Sponsor: Yale University

Target Recruit Count: 6030

Registration Number: NCT02753751

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer

Phase 1

Completed

Conditions: Liver Cancer

Interventions: Drug: superselective cTACE doxorubicin
Drug: whole liver lobe cTACE doxorubicin

First Posted Date: 2016-04-28

Last Posted Date: 2020-08-03

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT02753881

Locations: 🇺🇸
Yale University, Department of Diagnostic Radiology, New Haven, Connecticut, United States

Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Behavioral: Individual clinician-provided CBT
Behavioral: CBT4CBT

First Posted Date: 2016-04-18

Last Posted Date: 2023-11-18

Lead Sponsor: Yale University

Target Recruit Count: 99

Registration Number: NCT02742246

Locations: 🇺🇸
MCCA, Bridgeport, Connecticut, United States
🇺🇸
SATU, New Haven, Connecticut, United States

High-yield HIV Testing, Facilitated Linkage to Care, and Prevention for Female Youth in Kenya

Not Applicable

Completed

Conditions: Adolescent Behavior
HIV

Interventions: Behavioral: SMART Randomization 1 - Referral
Behavioral: SMART Randomization 1 - Referral and SMS
Behavioral: SMART Randomization 2 - SMS
Behavioral: High Risk Negative Cohort (N=185)
Behavioral: SMART Randomization 2 - Incentive
Other: All participants. Approximately (N=1200)

First Posted Date: 2016-04-13

Last Posted Date: 2021-11-02

Lead Sponsor: Yale University

Target Recruit Count: 1198

Registration Number: NCT02735642

Locations: 🇰🇪
Impact Research & Development Organization, Kisumu, Kenya

Imaging SV2A in Mood Disorders

Not Applicable

Recruiting

Conditions: Major Depressive Disorder
Post-Traumatic Stress Disorder

Interventions: Drug: Ketamine

First Posted Date: 2016-04-12

Last Posted Date: 2024-08-12

Lead Sponsor: Yale University

Target Recruit Count: 130

Registration Number: NCT02734602

Locations: 🇺🇸
PET Center, New Haven, Connecticut, United States

Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers

Phase 1

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Saracatinib

First Posted Date: 2016-04-08

Last Posted Date: 2020-01-14

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT02732587

Locations: 🇺🇸
CMHC, Substance Abuse Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy